Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è 30,16 € (-3,64%). La mediana è 28,12 € (-10,16%).

Acquista
  8
Mantieni
  7
Vendi
  0

Discussioni nella community

Non ci sono ancora discussioni su questo asset.

Avvia discussione

  • Double downgrade drives Trupanion stock sharply lower

    The stock of Trupanion fell about 6.4% in morning trading after Piper Sandler cut its rating from "Overweight" to "Neutral" and lowered the price target from $45 to $32. Piper Sandler cited declining puppy vet visits and more costly, aging COVID cohorts as headwinds for premium growth and underwriting margins. A simultaneous downgrade by Zacks intensified the sell-off, while the new price target, near the current share price, signals only limited short-term upside. » Altro su de.investing.com


  • Trupanion beats Q2 earnings forecast and highlights outlook for 2026

    Trupanion reported Q2/2026 earnings of $0.16 per share, beating the $0.1133 forecast, on revenue up 11% to $392.9m. Adjusted operating income from subscriptions rose 24% and subscription revenue grew 14% to $276.7m, while the number of insured pets increased 5% to 1.125m. The stock rose 6.7% after hours; management confirmed a 2026 revenue range of $1.584–1.601bn and adjusted operating income of $176–184m. Risks remain higher customer acquisition costs, ongoing veterinary price inflation and execution risks for new product options. » Altro su de.investing.com


  • Trupanion reaches 52-week low at $24.13

    Trupanion shares fell to a 52-week low of $24.13 after losing about 34% over the past year and roughly 40% in recent months. For Q4 2025 the company reported earnings per share of $0.13 (forecast $0.16) and revenue of $376.9 million (+12% year over year), slightly beating expectations. Analysts cut price targets (Cantor Fitzgerald 42→34 USD, Stifel 35→31 USD) citing growth and scaling concerns, while InvestingPro signaled possible undervaluation and upside; Trupanion also announced a research collaboration with the Human Animal Bond Research Institute. » Altro su de.investing.com


  • Trupanion falls to 52-week low of $24.30

    Trupanion shares hit a new 52-week low at $24.30, down about 31.7% year-to-date; the six-month performance is down nearly 38%. The company reported Q4 2025 EPS of $0.13 (expectation $0.16) on revenue of $376.9 million (+12% YoY, forecast $375.21 million). Analysts cut price targets (Cantor Fitzgerald 42 → 34 USD, Stifel 35 → 31 USD), citing growth and scaling issues, while InvestingPro sees an undervaluation of around 38% and expects profitability this year. Trupanion also announced a partnership with the Human Animal Bond Research Institute to support studies on human-animal relationships. » Altro su de.investing.com


  • Trupanion hits 52-week low after sharp share decline

    Trupanion shares closed at $24.49, marking a 52-week low after declines of 33.06% over the past year, 43% in six months and 31% year-to-date. Investors are worried about slowing growth and competitive pressure in the pet insurance industry, although a PEG of 0.19 suggests possible undervaluation. In Q4 2025, Trupanion missed the EPS expectation (0.13 vs. $0.16) while revenue rose 12% to $376.9 million; a partnership with the Human Animal Bond Research Institute was also announced. » Altro su de.investing.com

Nel 2022, Trupanion ha già distribuito 0,0078 € di dividendi. L'ultimo pagamento è avvenuto a aprile 2022.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Trupanion ha registrato ricavi pari a 358,08 Mln € e un utile netto di 8,19 Mln €
(EUR) settembre 2026
YoY
Ricavi 358,08 Mln 14,52%
Utile lordo 61,36 Mln 19,90%
Utile netto 8,19 Mln 63,74%
EBITDA 14,03 Mln 22,48%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
1,35 Mld €
Numero di azioni
43,27 Mln
Massimo/minimo a 52 settimane
35,26 € - 19,20 €
Dividendi No
Beta
1,30
Rapporto P/E
56,52
Rapporto PEG
0,76
Rapporto P/B
3,77
Rapporto P/S
0,96

Profilo aziendale

Trupanion, Inc., insieme alle sue controllate, offre assicurazioni sanitarie per cani e gatti su base di abbonamento mensile negli Stati Uniti, in Canada, a Porto Rico e in Australia. La società opera in due segmenti, Subscription Business e Other Business. Si rivolge ai proprietari di animali domestici e ai veterinari. In precedenza la società era nota come Vetinsurance International, Inc. e nel 2013 ha cambiato denominazione in Trupanion, Inc. La società è stata fondata nel 2000 ed ha sede a Seattle, Washington.

Nome
Trupanion
CEO
Margaret Rosemary Maria Tooth
Sede centrale Seattle, wa
Stati Uniti
Sito web
Settore
Finanza
Industria
Assicurazioni
Quotazione in borsa
18/07/2014
Dipendenti 1121

Simboli di borsa

Borsa Simbolo
NASDAQ
TRUP
London Stock Exchange
0LH0.L
Frankfurt
TPW.F
Düsseldorf
TPW.DU
London
0LH0.L
SIX
TPW.SW
München
TPW.MU
🍪

Parqet  usa i cookie. Scopri di più